These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 1531093

  • 21. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD, Lipsky PE.
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [Abstract] [Full Text] [Related]

  • 22. Role of interferon-gamma in T-cell responses to Semliki Forest virus-infected murine brain cells.
    Tomkins PT, Ward GA, Morris AG.
    Immunology; 1988 Mar; 63(3):355-62. PubMed ID: 2832313
    [Abstract] [Full Text] [Related]

  • 23. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD, Locksley RM, Tubbs C, Raff HV.
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [Abstract] [Full Text] [Related]

  • 24. The relationship between immune interferon production and proliferation in antigen-specific, MHC-restricted T cell lines and clones.
    Hecht TT, Longo DL, Matis LA.
    J Immunol; 1983 Sep; 131(3):1049-55. PubMed ID: 6193170
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
    Gastl G, Ebert T, Finstad CL, Sheinfeld J, Gomahr A, Aulitzky W, Bander NH.
    J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD, Heinzel FP, Shigekane VM, Fisher WL, Locksley RM.
    J Immunol; 1987 Aug 15; 139(4):1303-9. PubMed ID: 3112230
    [Abstract] [Full Text] [Related]

  • 31. Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules.
    Frey AB, Cestari S.
    Cell Immunol; 1997 May 25; 178(1):79-90. PubMed ID: 9184701
    [Abstract] [Full Text] [Related]

  • 32. Ia-specific mixed leukocyte reactive T cell hybridomas: analysis of their specificity by using purified class II MHC molecules in synthetic membrane system.
    Coeshott CM, Chesnut RW, Kubo RT, Grammer SF, Jenis DM, Grey HM.
    J Immunol; 1986 Apr 15; 136(8):2832-8. PubMed ID: 2420871
    [Abstract] [Full Text] [Related]

  • 33. Renal allograft rejection: protection of renal epithelium from natural killer cells by cytokine-induced up-regulation of class I major histocompatibility antigens.
    Lin Y, Proud G, Taylor RM, Kirby JA.
    Immunology; 1993 Jun 15; 79(2):290-7. PubMed ID: 8344707
    [Abstract] [Full Text] [Related]

  • 34. Accessory cell-T cell interactions involved in anti-CD3-induced T4 and T8 cell proliferation: analysis with monoclonal antibodies.
    Geppert TD, Lipsky PE.
    J Immunol; 1986 Nov 15; 137(10):3065-73. PubMed ID: 3095421
    [Abstract] [Full Text] [Related]

  • 35. Immune selection in murine tumors. Ph.d thesis.
    Svane IM, Engel AM.
    APMIS Suppl; 2003 Nov 15; (106):1-46. PubMed ID: 12739251
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S, Brighouse G, Kramer G, Wen L, Izui S, Merino J, Lambert PH.
    J Immunol; 1991 Apr 01; 146(7):2152-60. PubMed ID: 1672344
    [Abstract] [Full Text] [Related]

  • 38. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
    Nisticò P, Tecce R, Giacomini P, Cavallari A, D'Agnano I, Fisher PB, Natali PG.
    Cancer Res; 1990 Dec 01; 50(23):7422-9. PubMed ID: 1701342
    [Abstract] [Full Text] [Related]

  • 39. Specific prolongation of MHC class II disparate skin allografts by in vivo administration of anti-IFN-gamma monoclonal antibody.
    Rosenberg AS, Finbloom DS, Maniero TG, Van der Meide PH, Singer A.
    J Immunol; 1990 Jun 15; 144(12):4648-50. PubMed ID: 2112572
    [Abstract] [Full Text] [Related]

  • 40. OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells.
    Platzer E, Rubin BY, Lu L, Welte K, Broxmeyer HE, Moore MA.
    J Immunol; 1985 Jan 15; 134(1):265-71. PubMed ID: 3917276
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.